Sanofi Aventis, a large cap French pharmaceutical firm developed an effectual weight loss medication, Acomplia. This weight loss medication is to be employed is association with a proper diet plan and regular exercise regime to attain effective results.
Weight loss medication …
On April 3rd Sanofi-Aventis published that it still has high hopes for Rimonabant (Acomplia / Zimulti) to get aproval from the FDA in US, even though it was rejected by an advisory panel last year and recent clinical trial …
Acomplia, generic name rimonabant, suffered a new setback on March 4th when the social court in Berlin-Brandenburg upheld a previous court ruling that German patients taking Sanofi-Aventis’s diet drug will not be reimbursed by their health insurers.
While Acomplia …
Overweight and obesity are the two most common and recurring health problems that have affected millions of people across the globe. Many pharmaceutical companies provide different medical solutions for treatments regarding weight-loss. Developed by a French pharmaceutical company, Sanofi-Synthelabo, Acomplia …
Rimonabant is the new diet pill that made a huge impression in the obesity treatments. Rimonabant is the active force, the main ingredient of Acomplia. Rimonabant is the result of hard working scientists that wanted to make a diet pill …